Abstract: A new pharmaceutical compound for treating central nervous disorders, the compound comprising a therapeutically effective amount of valproic acid or pharmaceutically acceptable derivative thereof covalently bonded to myo-inositol. The invention also provides a composition, method for treating a patient and a method for obtaining the compound.
Type:
Grant
Filed:
March 15, 2006
Date of Patent:
July 27, 2010
Assignees:
Medipharma S.A., University Nacional De La Plata
Abstract: A new pharmaceutical compound for treating central nervous disorders, the compound comprising a therapeutically effective amount of valproic acid or pharmaceutically acceptable derivative thereof covalently bonded to myo-inositol. The invention also provides a composition, method for treating a patient and a method for obtaining the compound.
Type:
Application
Filed:
March 15, 2006
Publication date:
September 20, 2007
Applicants:
Medipharma S.A., Universidad Nacional De La Plata
Abstract: A number of new therapeutic uses have been found for compounds such as known local anesthetics which are quite different from the present therapeutic uses of these drugs. The uses include, for example; modulating lymphocytes, macrophages and other immune cell functions, or PMN functions; inhibiting the cytotoxic effect of polymorphonuclear neutrophils leucocytes; providing a protective effect on plasma cell membranes; and providing an antidote against intoxication by an intoxicants.
Type:
Grant
Filed:
February 19, 1998
Date of Patent:
October 31, 2000
Assignee:
Medipharma S.A.
Inventors:
Juan Carlos Mahiques, Ricardo Luis Elicabe, Raul Isidoro Koler, Ruben Martin Laguens, Enrique Leo Portiansky